Why Biden's FDA pick can't win confirmation until 2022
A plot to speed Robert Califf's FDA nomination through the Senate next month fell apart after the Biden administration failed to submit the necessary paperwork to Congress in time.
5 days ago
Califf's profitable industry ties spark fresh criticism
Robert Califf made more than $2.7 million over the last year as a senior adviser to Alphabet-owned Verily Life Sciences, according to new financial documents.
6 days ago
Booster recommendations catch up with states' reality
Federal regulators on Friday green-lit booster shots for American adults, opening the door to millions of new vaccine rounds and the potential to clear up some booster confusion.
7 days ago